
NYSE:MCD
This summary was created by AI, based on 14 opinions in the last 12 months.
McDonald's (MCD) is currently experiencing headwinds due to inflation and changing consumer habits, making investment opinions mixed. While some experts note the company's strong fundamentals, including steady cash flow and international growth, concerns about its price-to-earnings ratio (around 20-21x) persist, particularly as US consumers grapple with economic challenges. A significant portion of its customer base is feeling the strain of a K-shaped economy, which could impact sales. Moreover, the increase in beef prices poses a challenge, although there's optimism surrounding potential price relief in the coming months. Despite these challenges, many analysts see McDonald's as a defensive investment with considerable brand strength and growth potential in the long run.
We live in a country of two consumers: those flush with money and those struggling to buy at dollar stores. MCD reported today and shares fell. Same-store sales grew 4.3% YOY, but felt pressure from the Israel-Hamas war. More pressure came from consumers who are eating at home because packaged foods are more affordable than take-out.
It is adding more stores and raising prices by 10% which people are paying. More middle and higher income people are coming into their restaurants along with lower income customers eating there less often. It has spent 7 years improving the burgers and is now increasing the size of them. It reinvests profits more than the other chains.
MCD is a mature fast food franchisor that is now trading at 21.4x times' Forward P/E (historical averages in the last five years range from 21.2x to 25.2x). The balance sheet has net debt of $47B, and a net debt/EBITDA of 3.2x, which is quite leveraged, but given the predictability of the business, we think it is still okay. The company has generated healthy cash flow over the years, most of which has been used for dividend increases and share repurchases. Although long-term growth may be affected somewhat due to a healthier lifestyle, we think MCD could do well over the short term given the pricing power of the capital-light business model as a franchisor, which is valuable in an inflationary environment. We would nor really be concerned about the weight loss drugs. They could even have a net positive impact if consumers believe they are healthier overall and want to 'treat' themselves. Overall, we like MCD as a solid dividend grower name, and we are okay to add some here at the current valuation.
Unlock Premium - Try 5i Free
He holds it in more conservative portfolios. Looking back long-term, you can't get a chart that's much better. Yield is 2.1%, which he expects to remain stable and go higher over time. Expects 6.4% dividend growth, very strong. Great balance sheet and cashflow, well run. Low beta, 3/4 that of the S&P.
Was on her watchlist for a while. Pulled back, down 15% YTD, so she added to client portfolios about a week and a half ago. Global, 100 countries, 41K units. Very profitable business model of 94% franchised. So franchisees pay a royalty percentage of topline sales plus, uniquely, rent for the buildings and land (39% of total revenue). Cashflows are visible and defensible. Yield is 2.63%, dividend increases for 45 consecutive years.
(Analysts’ price target is $305.87)Quick service has lagged due to higher unemployment, diminishing savings, price increases. Renewed focus on value, scale helps them accomplish this.